New York State Teachers Retirement System Has $20.23 Million Stock Holdings in STERIS plc $STE

New York State Teachers Retirement System raised its position in STERIS plc (NYSE:STE) by 2.7% during the third quarter, Holdings Channel reports. The institutional investor owned 81,749 shares of the medical equipment provider’s stock after buying an additional 2,142 shares during the quarter. New York State Teachers Retirement System’s holdings in STERIS were worth $20,228,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in STE. Steigerwald Gordon & Koch Inc. acquired a new position in shares of STERIS during the third quarter valued at $25,000. Spurstone Advisory Services LLC bought a new stake in STERIS during the 2nd quarter worth about $29,000. Geneos Wealth Management Inc. raised its holdings in STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares during the last quarter. TruNorth Capital Management LLC acquired a new position in STERIS during the 3rd quarter valued at about $37,000. Finally, Loomis Sayles & Co. L P acquired a new position in STERIS during the 2nd quarter valued at about $54,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at STERIS

In other news, VP Julia Madsen sold 5,008 shares of the business’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the transaction, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. The trade was a 31.86% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP John Adam Zangerle sold 15,000 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. This represents a 30.82% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 25,044 shares of company stock valued at $6,586,218 over the last three months. 1.07% of the stock is currently owned by corporate insiders.

STERIS Trading Up 1.5%

NYSE:STE opened at $260.61 on Tuesday. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. STERIS plc has a 1-year low of $204.28 and a 1-year high of $268.60. The firm has a market capitalization of $25.58 billion, a price-to-earnings ratio of 37.44 and a beta of 1.03. The business’s 50-day moving average price is $257.99 and its two-hundred day moving average price is $246.01.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. STERIS had a return on equity of 14.43% and a net margin of 12.07%.During the same period in the prior year, the business posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, equities analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th were issued a $0.63 dividend. The ex-dividend date was Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is 36.21%.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research report on Friday. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $273.50.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.